<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03457688</url>
  </required_header>
  <id_info>
    <org_study_id>16002n_</org_study_id>
    <nct_id>NCT03457688</nct_id>
  </id_info>
  <brief_title>Effect of Prebiotic Fructans to Reduce Number of Febrile Infections in Children</brief_title>
  <official_title>Double-blind, Randomized Placebo-controlled, Multi-center Trial Investigating the Effect of Prebiotic Inulin-type Fructans on Infectious Incidence in Children Aged 3 to 6 Years</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beneo-Institute</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beneo-Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to confirm the effectiveness of chicory-derived prebiotic inulin-type fructans
      on the reduction of the number of febrile infections diagnosed by the paediatrician in
      children.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 19, 2016</start_date>
  <completion_date type="Actual">May 1, 2017</completion_date>
  <primary_completion_date type="Actual">May 1, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of febrile infectious episodes diagnosed by paediatrician</measure>
    <time_frame>6 months period</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of any infectious episodes diagnosed by paediatrician</measure>
    <time_frame>6 months period</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of episodes with symptoms of illnesses indicating a viral or bacterial infection</measure>
    <time_frame>6 months period</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of febrile infectious episodes diagnosed by the paediatrician</measure>
    <time_frame>6 months period</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of any infectious episode</measure>
    <time_frame>6 months period</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of episodes with symptoms of illnesses indicating a viral or bacterial infection</measure>
    <time_frame>6 months period</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days of absence from day-care of the child due to infectious episodes and/or symptoms of dysbiosis (diarrhoea) following antibiotic treatment</measure>
    <time_frame>6 months period</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of paediatrician´s consultations due to infectious disease and/ or symptoms of dysbiosis (diarrhoea) following antibiotic treatment</measure>
    <time_frame>6 months period</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospitalization days due to infectious disease and/or symptoms of dysbiosis</measure>
    <time_frame>6 months period</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of days (parents questionnaire and diary) of caretaker´s absenteeism from work due to infectious episodes and/or symptoms of dysbiosis of the child</measure>
    <time_frame>6 months period</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of episodes on antibiotic treatment</measure>
    <time_frame>6 months period</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of days on antibiotic treatment</measure>
    <time_frame>6 months period</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of episodes of medication use (including prescribed/ non-prescribed medication and antibiotics/ non-antibiotics)</measure>
    <time_frame>6 months period</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of days of medication use (including prescribed/ non-prescribed medication and antibiotics/ non-antibiotics)</measure>
    <time_frame>6 months period</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life reported by the parents according to standardized questionnaire</measure>
    <time_frame>6 months period</time_frame>
    <description>Parent Diary (scale: no, minor, moderate, significant changes, Not known)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analysis of stool samples in a subset of children: microbiota changes</measure>
    <time_frame>6 months period</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Incidence of gastrointestinal discomfort</measure>
    <time_frame>6 months period</time_frame>
    <description>Main Parameters of safety</description>
  </other_outcome>
  <other_outcome>
    <measure>Body Weight</measure>
    <time_frame>6 months period</time_frame>
    <description>Main Parameters of safety</description>
  </other_outcome>
  <other_outcome>
    <measure>Body Height</measure>
    <time_frame>6 months period</time_frame>
    <description>Main Parameters of safety</description>
  </other_outcome>
  <other_outcome>
    <measure>Side effects (Questionnaire)</measure>
    <time_frame>6 months period</time_frame>
    <description>Main Parameters of safety</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">850</enrollment>
  <condition>Infectious Disease</condition>
  <condition>Children, Only</condition>
  <condition>Diet Modification</condition>
  <arm_group>
    <arm_group_label>prebiotic inulin-type fructans</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo maltodextrin</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>prebiotic inulin-type fructans</intervention_name>
    <arm_group_label>prebiotic inulin-type fructans</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>placebo maltodextrin</intervention_name>
    <arm_group_label>placebo maltodextrin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject is healthy at the time of pre-examination

          -  Subject is aged 3-6 years at the time of pre-examination

          -  Subject attends a kindergarten at the time of pre-examination

        Exclusion Criteria:

          -  Suffering from current infection or has suffered from infection in previous 7 days

          -  Intake of antibiotics and/or laxatives in the previous 14 days prior to start of the
             intervention

          -  children with known gastrointestinal disease or malformation

          -  children with congenital or acquired immunodeficiency

          -  children with food intolerance, food allergy

          -  children that regularly consume (more than 3 times per week) probiotic products or a
             food supplement containing prebiotics

          -  children involved in any clinical or food study within the preceding 6 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>6 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tamás Decsi, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Paediatrics, University of Pécs, Hungary</affiliation>
  </overall_official>
  <reference>
    <citation>Lohner S, Küllenberg D, Antes G, Decsi T, Meerpohl JJ. Prebiotics in healthy infants and children for prevention of acute infectious diseases: a systematic review and meta-analysis. Nutr Rev. 2014 Aug;72(8):523-31. doi: 10.1111/nure.12117. Epub 2014 Jun 5. Review.</citation>
    <PMID>24903007</PMID>
  </reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 21, 2018</study_first_submitted>
  <study_first_submitted_qc>March 1, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 7, 2018</study_first_posted>
  <last_update_submitted>March 8, 2018</last_update_submitted>
  <last_update_submitted_qc>March 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Infection</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Levan</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

